| | | | |
CUSIP No. 03940C 10 0 | | SCHEDULE 13D/A1 | | Page 8 of 9 |
Item 1. Security and Issuer.
This statement on Schedule 13D amends and supplements the statement on Schedule 13D originally filed on February 17, 2022 (“Schedule 13D,” and as amended by this Amendment No. 1, the “Statement”) with respect to the shares of common stock, par value $0.001 per share (the “Common Stock”), of Arcellx, Inc., a Delaware corporation (the “Issuer”). The address of the Issuer’s principal executive offices is 25 West Watkins Mill Road, Suite A, Gaithersburg, Maryland 20878. This amendment is filed to reflect its new percentage beneficial ownership in the Issuer, which was decreased as a result of an increase in the Issuer’s Common Shares outstanding. Unless otherwise indicated, each capitalized term used but not defined herein shall have the meaning assigned to such term in the Schedule 13D.
Item 4. Purpose of Transaction.
The response set forth in Item 4 of the Schedule 13D is hereby supplemented as follows:
On June 21, 2022, the Issuer closed an underwritten public secondary offering of 7,000,000 shares of its Common Stock (the “Offering”). SR One did not participate in the Offering and, as a result, the percentage of Common Stock beneficially owned by the Reporting Persons decreased from 15.8% to 12.9%.
Item 5. Interest in Securities of the Issuer.
The response set forth in Item 5 of the Schedule 13D is hereby amended by deleting the previous response in its entirety and replacing it with the following:
(a), (b) The information contained in rows 7, 8, 9, 10, 11, and 13 on each of the cover pages of this Statement is incorporated by reference in its entirety into this Item 5.